Advertisement

Neurological Sciences

, Volume 39, Issue 12, pp 2213–2216 | Cite as

Parkinsonism and multiple sclerosis, what is behind?

  • Funda Uysal Tan
Letter to the Editor

Dear Editor,

The awareness of the coexistence of both diseases in some patients resulted in an ongoing debate on either causal or coincidental relationship between multiple sclerosis (MS) and parkinsonism [1, 2]. Present data offers some rationale for both theories. In the cases presented in the literature, mostly, Parkinson’s disease (PD) follows the MS [1, 2].

A 43-year-old man complained of tremor of the left arm in 2010. Neurological examination revealed resting tremor of the left upper extremity with mild bradykinesia and mild rigidity, and hypomimia. He had a normal-based gait, with absent left arm swing. The symptoms markedly improved by administration of pramipexole.

In his history, he had mild vertigo, ataxia, and gait disturbances in 2002. Brain magnetic resonance imaging (MRI) revealed demyelinating lesions of the central nervous system consistent with MS: multiple hyperintense lesions located in periventricular areas, the corpus callosum, and the subcortical white matter of...

Notes

Compliance with ethical standards

Conflict of interest

The author declares that there is no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

The patient was well informed and permission obtained for report as no identifying personal data is also used in case description.

References

  1. 1.
    Nociti V, Bentivoglio AR, Frisullo G, Fasano A, Soleti F, Iorio R, Loria G, Patanella AK, Marti A, Tartaglione T, Tonali PA, Batocchi AP (2008) Movement disorders in multiple sclerosis: causal or coincidental association? Mult Scler Nov 14(9):1284–1287CrossRefGoogle Scholar
  2. 2.
    Etemadifar M, Afshar F, Nasr Z, Kheradmand M (2014) Parkinsonism associated with multiple sclerosis: a report of eight new cases and a review on the literature. Iran J Neurol 13(2):88–93PubMedCentralGoogle Scholar
  3. 3.
    Barbagallo G, Arabia G, Lupo A, Sabatini U, Quattrone A (2016) Midbrain hemiatrophy and nigral rarefaction in a patient with hemiparkinsonism-hemiatrophy syndrome. Mov Disord 31(11):1756–1757CrossRefGoogle Scholar
  4. 4.
    Ohta K, Obara K (2006) Hemiparkinsonism with a discrete lacunar infarction in the contralateral substantia nigra. Mov Disord 21(1):124–125CrossRefGoogle Scholar
  5. 5.
    Zivadinov R, Cox JL (2007) Neuroimaging in multiple sclerosis. Int Rev Neurobiol 79:449–474CrossRefGoogle Scholar
  6. 6.
    Sun XY, Wang L, Cheng L, Li NN, Lu ZJ, Li JY, Peng R (2017) Genetic analysis of FGF20 in Chinese patients with Parkinson’s disease. Neurol Sci 38(5):887–891CrossRefGoogle Scholar
  7. 7.
    Lesnick TG, Sorenson EJ, Ahlskog JE, Henley JR, Shehadeh L, Papapetropoulos S, Maraganore DM (2008) Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway. PLoS One 3:e1449CrossRefPubMedCentralGoogle Scholar
  8. 8.
    Li X, Sundquist J, Sundquist K (2012) Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: a nationwide epidemiological study from Sweden. Neurodegener Dis 10(1–4):277–284CrossRefGoogle Scholar
  9. 9.
    Rugbjerg K, Friis S, Ritz B, Schernhammer ES, Korbo L, Olsen JH (2009) Autoimmune disease and risk for Parkinson disease: a population-based case control study. Neurology 73:1462–1468CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Nielsen NM, Pasternak B, Stenager E, Koch-Henriksen N, Frisch M (2014) Multiple sclerosis and risk of Parkinson’s disease: a Danish nationwide cohort study. Eur J Neurol 21:107–111CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Neurology ClinicMemorial Ankara HospitalAnkaraTurkey

Personalised recommendations